Literature DB >> 9545754

Plasma concentrations of antipsychotic drugs in psychiatric inpatients.

H Tokunaga1, K Kudo, T Imamura, N Jitsufuchi, Y Ohtsuka, N Ikeda.   

Abstract

In current psychiatric therapy, two or more kinds of antipsychotic drugs are usually prescribed in Japan. However, there are few data on the therapeutic plasma concentrations of antipsychotic drugs or on the correlation between the daily dose and the plasma concentration, in cases where several antipsychotic drugs had been prescribed for each patient. We measured the therapeutic plasma concentrations of 9 antipsychotic drugs in 24 psychiatric inpatients during a 6-month period. They were treated with fixed dosages of antipsychotic drugs. Plasma samples were collected early in the morning once a month, and the concentrations of antipsychotic drugs were determined by gas chromatography with nitrogen phosphorus detection, high-performance liquid chromatography (HPLC) with fluorescence detection and HPLC with UV detection. The plasma levels of chlorpromazine, levomepromazine, thioridazine, haloperidol, bromperidol, zotepine, oxypertine, sulpiride and sultopride were 21.8-92.4, 31.7-156, 101-203, 16.4-56.2, 2.72-11.7, 13.6-84.0, 29.9-80.4, 70.1-1,120 and 35.7-2,990 ng/ml, respectively. A linear correlation between the daily dose and the plasma concentration was noted for sultopride, levomepromazine, sulpiride, haloperidol, chlorpromazine and zotepine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9545754

Source DB:  PubMed          Journal:  Nihon Hoigaku Zasshi        ISSN: 0047-1887


  6 in total

1.  Region specific distribution of levomepromazine in the human brain.

Authors:  J Kornhuber; H Weigmann; J Röhrich; J Wiltfang; S Bleich; I Meineke; R Zöchling; S Härtter; P Riederer; C Hiemke
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.

Authors:  Johannes Kornhuber; Jens Wiltfang; Peter Riederer; Stefan Bleich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

3.  Interactions of chlorpromazine with milk proteins.

Authors:  J Bhattacharyya; K P Das
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

4.  Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment.

Authors:  Y Chertkow; O Weinreb; M B H Youdim; H Silver
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

5.  The antipsychotic drug chlorpromazine inhibits HERG potassium channels.

Authors:  Dierk Thomas; Kezhong Wu; Sven Kathöfer; Hugo A Katus; Wolfgang Schoels; Johann Kiehn; Christoph A Karle
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

6.  Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study.

Authors:  Ramakotaiah Mogili; Kanchanamala Kanala; Balasekhara Reddy Challa; Babu Rao Chandu; Chandrasekhar Kottapalli Bannoth
Journal:  Sci Pharm       Date:  2011-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.